InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Legorreta Pablo G., Director. Director active across 2 companies, notably Royalty Pharma plc. Cumulatively, 5 disclosures have been published. Total volume traded: €61m. The latest transaction was disclosed on 16 June 2020 — C. Regulator: SEC (Form 4). All data is free.
Declarations5 total
0493,750 shares0
Class A Ordinary Shares
SEC:0000950103-22-006475:0·
€30m22,666,667 shares@ €1.34550.0% of flow
Common Stock
SEC:0000899243-22-003857:0·
Ideal exit: 28 Oct 2022 (T+270)
€30m22,666,667 shares@ €1.345100.0% of flow
Common Stock
SEC:0000899243-22-003857·
Ideal exit: 28 Oct 2022 (T+270)
01,040,410 shares0
Class A Ordinary Shares
SEC:0000950103-21-007075·
01,040,410 shares0
Class A Ordinary Shares
SEC:0000950103-21-007075:0·
5 of 5 declarations
About Legorreta Pablo G.
Pablo G. Legorreta is the CEO, Chairman of the Board, and Board Member at Royalty Pharma plc and Epizyme, Inc. He is responsible for the strategic direction of these companies, ensuring alignment of operations with overall objectives. His leadership and vision are essential in guiding these organizations through a competitive landscape.
